Newsbenzinga
Abbott Bypasses Appeals Process To Settle Ongoing Premature Infant Formula Litigation
· Published
Article summary
Abbott agreed to pay $670 million to resolve the Gill lawsuit and 2,000 other NEC claims involving its specialty preterm infant formulas.
An excerpt from the original article.
Comments —
Loading comments…